Beam Therapeutics: SCD Catalysts Have Untapped Upside Potential

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...

Q3 2025 Review: Bears Capture Headlines While Bulls And Gold Bugs Garner Profits

The spot price of gold has outperformed the S&P 500 Index for the period beginning January 1, 2000, through September 30 of ...